SYNTHOS RESEARCH

CMS Energy CMS

Utilities · Regulated Electric · Synthos Deep Dive · 2026-07-03

$68.21
Hold

The Overview

CMS Energy is the parent of Consumers Energy, the company that delivers electricity and natural gas to about 1.9 million electric and 1.8 million gas customers across most of Michigan. It's a regulated utility — a government commission approves what it can charge, so its profits are steady and predictable, like a toll road for power. It pays a dividend of about 2.9% a year.

The catch: the stock is priced about right — not cheap, not expensive. You're paying a fair price for a safe, slow grower. Our verdict is Watch — there's nothing wrong with the company, but at today's price there isn't much upside to reach for, so it's a "keep an eye on it, buy on a dip" name rather than a buy-now.

Here's what our three scores mean in everyday terms:

The one big worry: CMS depends on Michigan regulators letting it charge enough to earn a fair return and recover the billions it spends on the grid. A bad rate ruling, or higher interest rates on its large debt load, would pinch profits.


Putting a number on it: our fair-value estimate is $77 against a current price of $68.21 — real upside if our numbers are right.

Our summary metrics

Downside Risk (lower = safer)4/10Moderate

Low beta (0.35) & regulated cash flows cushion downside, but 5.8× net-debt/EBITDA and 21× earnings leave little margin.

Growth Quality5/10Moderate

Steady ~7-8% EPS CAGR and rate-base growth, but low ROIC (3.6%) and no margin inflection — utility-grade, not high-quality growth.

Exponential Potential2/10Low

Regulated single-state utility; ~5% revenue CAGR, decelerating, no multibagger optionality. Structurally capped.

Fair value$77 $63–$86
What does “fair value” mean?

Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.

The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.

What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.

Exponential Potential

Exponential Potential2/10Low

Regulated single-state utility; ~5% revenue CAGR, decelerating, no multibagger optionality. Structurally capped.

What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.

Deeper analysis

Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.

Check our number Market-implied growth ≈ 8%/yr This isn’t how we calculate fair value — it’s public math you can verify yourself. To justify today’s $68, earnings would have to compound roughly 8% a year for 10 years (9% discount rate). Analysts forecast ~8%/yr, so the market is pricing in about what the Street expects.

Reference table

Street consensus$80 (high $83 / low $74; 17 Buy · 13 Hold · 0 Sell) — context, not our anchor
Valuation21× trailing EPS · 20× FY26E · 19× FY27E · 15× FY30E · EV/S 4.9× · EV/EBITDA 13.3× · div yield 2.9%
TechnicalsMild uptrend — $77.73, −2.8% off 52-wk high, above 50/200-DMA, RSI 70 (stretched), +10.8% 12-mo (SPY +20.6%)
ConvictionLow / none — 0 net-bullish voices, 0 KB claims. Call rests entirely on fundamentals & quant
Position sizingIf owned, a defensive income sleeve holding (~1–3%), not a growth position

What the company says Issuer statements only — no independent expert coverage yet for CMS

“CMS's advance non-coverage of FDA-approved Alzheimer's drugs makes no sense; a clean phase 3 success will force reopening and reversal of that policy.”
Eli Lilly CEOmanagementconviction 702022-05-04

These are the company’s own claims (management voices are always half-weighted in our scoring, never treated as independent validation) — shown because they’re the only claims on record for this name. Treat as company guidance, not third-party analysis.

Price & moving averages 12 months · 50 & 200-day averages · 52-week range

6771747781Aug '25Nov '25Jan '26Apr '26Jun '26Aug '2652w hi $80200-DMA 7450-DMA 7352w lo $68Price 68

Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.

Data summary: last close $68.21, 7% below the 50-day average ($73), 7% below the 200-day average ($74) — a downtrend. 15% below the 52-week high of $80, 0% above the 52-week low of $68.

Bollinger Bands 20-day average ± 2 standard deviations

6770747882Aug '25Nov '25Jan '26Apr '26Jun '26Aug '2620-day avg 70Price 68

The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.

Data summary: price $68.21 is currently inside the band (band $68–$73).

RSI (14) momentum gauge · 0–100

705030Aug '25Nov '25Jan '26Apr '26Jun '26Aug '26RSI 33.4

Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 33.

MACD 12 / 26 / 9 · trend & momentum

0Aug '25Nov '25Jan '26Apr '26Jun '26Aug '26signal -1.1MACD -1.2

The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.

Data summary: MACD is currently below its signal line by 0.09, negative momentum.

Relative performance vs S&P 500 & its sector (XLU (sector)), set to 100 a year ago

94101108115122Aug '25Nov '25Jan '26Apr '26Jun '26Aug '26S&P 500 119XLU (sector) 101CMS 96

Solid = CMS · dashed = S&P 500 · dotted = XLU (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.

Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate

036912$8BFY23EPS $3$8BFY24EPS $3$8BFY25EPS $4$9BFY26EEPS $4$9BFY27EEPS $4$10BFY28EEPS $4$10BFY29EEPS $5$10BFY30EEPS $5

Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.

Key stats an RIA wants

Price$68.21
Market cap$21B
P/E trailing20×
P/E FY26E / FY27E18× / 16×
EV / Sales4.6×
EV / EBITDA13.0×
Gross margin69.7%
Net margin11.6%
Dividend yield3.30%
Beta0.339
52-wk range$68 – $80
RSI(14)44
50 / 200-DMA$73 / $74
12-mo return+-6% (SPY +19%)
Street target$82 ($78–$86)
Analyst grades16 Buy · 14 Hold · 0 Sell
FMP ratingC+
Next earnings2026-07-30 (Q2'26 earnings; Street EPS est $0.79)

1. What it is

CMS Energy Corporation (NYSE: CMS) is a Jackson, Michigan-based energy holding company incorporated in 1987, whose principal business is Consumers Energy, a rate-regulated electric and gas utility serving most of Michigan's lower peninsula. It operates through three segments: Electric Utility (generation, distribution and sale of electricity — coal, wind, gas, renewables, oil and nuclear), Gas Utility (purchase, transmission, storage and distribution of natural gas), and NorthStar Clean Energy (independent power production and renewables marketing). It serves ~1.9 million electric and ~1.8 million gas customers and employs ~8,433 people. Fiscal year ends December 31.

Revenue mix (FY2025, from FMP product segmentation):

There is no meaningful international, product-diversification, or secular-growth angle here. This is a pure regulated-utility rate-base compounder: it spends capital on the grid, the regulator lets it earn a return on that capital, and earnings grow with the rate base.

2. The expert thesis (no coverage — stated plainly)

There is no expert coverage of CMS in the Synthos knowledge base. The claims file returns total_claims: 0, net_bullish_voices: 0, and an empty top array. No independent voice we track — bullish or bearish — has published a distilled, traceable view on this name.

What that means for this note, honestly: this verdict is entirely fundamentals- and quant-driven. There is no conviction-panel signal to lean on, and we will not manufacture one. Regulated utilities rarely attract the kind of thesis-driven expert commentary our KB indexes (they are cash-flow-and-regulation stories, not narrative stories), so the absence of coverage is itself unsurprising and is not, on its own, a negative signal. It simply means every judgment below rests on the reported financials, the analyst estimates (FMP), management's own guidance (§9), and the quant scoring framework — not on the Synthos expert panel. Weight this note accordingly.

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):

Score0–10The read
Downside Risk (lower = safer)4 · Moderate-LowBeta 0.35 and regulated, recession-resistant cash flows cushion the downside; offset by 5.8× net-debt/EBITDA (rate-sensitive) and a full 21× earnings multiple that leaves little valuation margin.
Growth Quality5 · AverageDependable ~7–8% EPS CAGR and steady rate-base growth, but ROIC is only ~3.6% and ROE ~12% with no margin inflection — utility-grade reliability, not high-quality compounding.
Exponential Potential2 · LowSingle-state regulated utility; ~5% revenue / ~8% EPS CAGR that decelerates over the estimate window. No accelerating growth, no TAM expansion, no optionality — structurally capped by design.

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.

CaseKey assumptionsFair value
BullConstructive Michigan rate cases, data-center / electrification load lifts rate-base growth to the high end; FY27E EPS reaches ~$4.30 and the multiple holds a premium ~20× on rate-quality earnings.~$86 (+11%)
Base (our anchor)Estimates roughly hit — FY27E EPS ~$4.18; a dependable 6–8% grower with a 2.9% yield earns a market-utility ~18.5×.~$77 (≈ flat)
BearAdverse rate ruling or higher-for-longer rates compress the levered balance sheet; FY27E EPS slips to ~$4.05 and the multiple de-rates to ~15.5×.~$63 (−19%)

Synthos fair value = the base case, ~$77 (≈ flat), with the full $63–$86 span as the honest range. Our anchor sits just below the Street's $80 consensus — we see the stock as roughly fairly priced rather than modestly cheap. The asymmetry is mildly unfavorable: ~+11% to the bull vs ~−19% to the bear. This is a tracked call — the Forecaster Scorecard grades it once it matures.

4. Exponential Potential

Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). CMS is neither an exponential nor even a high-return compounder — it is a regulated rate-base grower, and we score it honestly low:

Exponential Potential: Low (2/10). Own CMS, if at all, for the dividend and stability, not for growth. This is the opposite end of the spectrum from a Synthos flagship candidate — and scoring it a 2 (not a default 5) is exactly the differentiation the framework demands.

5. Financials (real numbers — FMP annual/quarterly)

6. Valuation — priced in or room?

CMS trades at 21× trailing EPS, 4.9× EV/sales, 13.3× EV/EBITDA, and a 2.9% dividend yield — right in line with the regulated-utility peer group, neither a discount nor a premium. On live consensus the forward multiple steps down as expected earnings grow: 20× (FY26E) → 19× (FY27E) → 17× (FY28E) → 15× (FY30E). The PEG is unattractive at ~2.7× (21× trailing on ~8% growth), which is simply the reality of utilities in a moderate-rate world: you pay a bond-like multiple for bond-like growth plus a yield.

A simple dividend-plus-growth read: ~2.9% yield + ~7% EPS/dividend growth ≈ ~10% expected total return if the multiple holds — respectable, but fully dependent on no multiple compression, which is the rate-sensitivity risk. Street targets (context): consensus $80, high $83, low $74 — a tight ~12% band that itself signals "fairly valued, low dispersion." Our $77 base FV is a touch below consensus: we see the stock as trading at roughly fair value with balanced risk. Not a value buy; a fairly-priced-quality-utility hold.

7. Technicals (computed from EOD price history)

8. Moat & competitive position

CMS's "moat" is regulatory, not competitive: as the regulated monopoly provider across most of lower-Michigan, it faces no direct competitor for its distribution franchise. That is durable but also a ceiling — its returns are capped by the Michigan Public Service Commission's allowed return on equity, so it cannot out-earn its regulator no matter how well it operates. The moat protects the downside (stable, monopoly cash flows) far more than it enables upside (returns are set, not won).

Peer set (market cap): the closest regulated-utility comparables are DTE Energy $32B (the other big Michigan utility and the truest peer), Southern Co $110B, Fortis $30B, Edison International $29B, FirstEnergy $28B, Evergy $20B, Alliant Energy $20B. CMS sits mid-pack on scale and valuation. Versus DTE — its in-state mirror — CMS carries a similar multiple and growth profile; there is no clear per-unit advantage that would justify a premium. The FMP peer list also includes non-comparable foreign names (Eletrobrás, Korea Electric) that we disregard.

9. Management, capital allocation & guidance

10. Catalysts & what to watch

Thesis tripwires (what would change the call): an adverse rate-case ruling that cuts allowed ROE; EPS guidance revised below the 6–8% band; net-debt/EBITDA drifting above ~6× without offsetting rate relief; or a multiple re-rating toward the low end of the peer group on higher rates.

11. Key risks

12. Verdict, position sizing & monitoring

Watch. CMS is a well-run, low-beta, regulated Michigan utility delivering exactly what it promises — steady ~7–8% EPS growth, a reaffirmed $3.83–$3.90 FY26 guide, and a ~2.9% dividend. The problem is not quality; it is price. At ~$77 against a ~$77 base-case fair value and an $80 Street consensus, the stock is roughly fairly valued, with mildly unfavorable asymmetry (~+11% bull vs ~−19% bear) and an overbought (RSI 70) near-term technical setup. There is nothing to chase here and nothing broken to avoid — the definition of a Watch.


Provenance & disclosures